Ce6 was the selected photosensitizer and NVP-BEZ235 was used due to its ability to inhibit the PI3K/AKT/mTOR pathway that is related to tumor progression and proliferation and inhibit the repair of DNA damage in tumor cells. The gene discussed is AKT1; the disease is neoplasm.